This post was originally published on this site
Earlier in the day, Moderna (NASDAQ:MRNA) said the FDA extended the emergency use authorization of a booster dose of its COVID-19 vaccine to all adults aged 18 and older.
A U.S. Centers for Disease Control and Prevention advisory panel is expected to meet later in the day to discuss whether to recommend the booster doses for the broader population.
